The Use of Low Molecular Weight Heparin Reduced the Fetal Fraction and Rendered the Cell-Free DNA Testing for Trisomy 21 False Negative

Ultrasound in Obstetrics and Gynecology - United States
doi 10.1002/uog.17473
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Re: Low-Molecular-Weight Heparin Associated With Reduced Fetal Fraction and Subsequent False- Negative Cell-Free DNA Test Result for Trisomy 21

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2018English

The Fetal Fraction of Cell-Free DNA in Maternal Plasma Is Not Affected by a Priori Risk of Fetal Trisomy

Journal of Maternal-Fetal and Neonatal Medicine
GynecologyChild HealthPediatricsPerinatologyObstetrics
2012English

Controversies in Pregnancy Management After Prenatal Diagnosis of a Twin Pregnancy Discordant for Trisomy 21 Diagnosed by Cell-Free Fetal DNA Testing

SOJ Gynecology , Obstetrics & Women's Health
2017English

The Price of Abandoning Diagnostic Testing for Cell Free Fetal Dna Screening

Prenatal Diagnosis
GynecologyGeneticsObstetrics
2018English

Low Molecular Weight Heparin

Reactions Weekly
2014English

Low Molecular Weight Heparin

Journal of Cardiothoracic and Vascular Anesthesia
Cardiovascular MedicineAnesthesiologyPain MedicineCardiology
1992English

Low Molecular Weight Heparin

Reactions Weekly
2013English

Low Molecular Weight Heparin

2020English

Capillary ElectrophoresisMass Spectrometry for the Analysis of Heparin Oligosaccharides and Low Molecular Weight Heparin

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy